Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » News & Analysis

News & Analysis


China biotech company and industry news and analysis...

Recent Articles

  BSD Medical and Dalian Orientech Gain China Approval for Cancer Hypothermia Device
  Week in Review: Blackstone Buys a $100 Million Stake in China Medical Device Company
  Sagent-Hengrui Partnership Launches Second Cancer Drug in US
  Livzon Mabpharm to Develop Epirus Biosimilars in China
  iHealth of Tianjin Raises $25 Million for Mobile Health Monitoring
  Blackstone Invests $100 Million In Device Maker Suzhou Xinrong
  Biocept Looks toward China to Market Cancer Diagnosis Technology
  GSK Faces $489 Million Fine in China Bribery Case
  CSPC Pharma to Support Drug Discovery Work at Columbia University
  CASI Pharma Pays $11.5 Million for China Rights to Three Spectrum Drugs


Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
Hope to see you there!
ChinaBio® Events
ChinaBio Leadership Retreat 2014
Suzhou, China
October 23-24, 2014
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors